Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Saved in:
| Title: | Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. |
|---|---|
| Authors: | Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany., Durante MA; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maclachlan KH; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weisel K; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Blood cancer discovery [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 450-463. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40402512 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Diamond+B%22">Diamond B</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Chahar+D%22">Chahar D</searchLink>; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Jain+MD%22">Jain MD</searchLink>; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Poos+AM%22">Poos AM</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Durante+MA%22">Durante MA</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Ziccheddu+B%22">Ziccheddu B</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Kaddoura+M%22">Kaddoura M</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Papadimitriou+M%22">Papadimitriou M</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Maclachlan+KH%22">Maclachlan KH</searchLink>; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Jelinek+T%22">Jelinek T</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Davies+FE%22">Davies FE</searchLink>; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Figura+NB%22">Figura NB</searchLink>; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Morgan+GJ%22">Morgan GJ</searchLink>; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Fenk+R%22">Fenk R</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Usmani+S%22">Usmani S</searchLink>; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Landgren+O%22">Landgren O</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schatz+JH%22">Schatz JH</searchLink>; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Maura+F%22">Maura F</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 450-463. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40402512 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2643-3230.BCD-24-0328 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 450 Titles: – TitleFull: Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diamond B – PersonEntity: Name: NameFull: Chahar D – PersonEntity: Name: NameFull: Jain MD – PersonEntity: Name: NameFull: Poos AM – PersonEntity: Name: NameFull: Durante MA – PersonEntity: Name: NameFull: Ziccheddu B – PersonEntity: Name: NameFull: Kaddoura M – PersonEntity: Name: NameFull: Papadimitriou M – PersonEntity: Name: NameFull: Maclachlan KH – PersonEntity: Name: NameFull: Jelinek T – PersonEntity: Name: NameFull: Davies FE – PersonEntity: Name: NameFull: Figura NB – PersonEntity: Name: NameFull: Morgan GJ – PersonEntity: Name: NameFull: Mai EK – PersonEntity: Name: NameFull: Weisel K – PersonEntity: Name: NameFull: Fenk R – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Usmani S – PersonEntity: Name: NameFull: Landgren O – PersonEntity: Name: NameFull: Locke FL – PersonEntity: Name: NameFull: Goldschmidt H – PersonEntity: Name: NameFull: Schatz JH – PersonEntity: Name: NameFull: Weinhold N – PersonEntity: Name: NameFull: Maura F IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 09 Text: 2025 Sep 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2643-3249 Numbering: – Type: volume Value: 6 – Type: issue Value: 5 Titles: – TitleFull: Blood cancer discovery Type: main |
| ResultId | 1 |